GlassScriptPhysician profile
David J Weissberg
NPI 1720013097
$3,430.92
in general payments reported to CMS, 2019-2025
20 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $365 · 2021: $591 · 2022: $608 · 2023: $254 · 2024: $888 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $888 · Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $888.39 |
| Food and Beverage | $460.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $1,620.78 | 2021-2025 | Biobrace 23mm, Linvatec Arthroscopy |
| Pacira Therapeutics, INC. | $327.73 | 2019-2021 | |
| Horizon Therapeutics Plc | $293.72 | 2019-2022 | |
| Ermi LLC | $265.26 | 2019-2020 | |
| Depuy Synthes Sales INC. | $202.54 | 2019-2022 | |
| Dynasplint Systems INC. | $140.67 | 2021 | |
| Zimmer Biomet Holdings, INC. | $138.58 | 2022 | |
| Stryker Corporation | $89.96 | 2019-2023 | Inspace |
| Djo, LLC | $49.28 | 2022 | |
| Smith+Nephew, INC. | $44.47 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $44.12 | 2022-2025 | Euflexxa |
| Kowa Pharmaceuticals America, INC. | $41.80 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $35.00 | 2023 | Iovera, Zilretta |
| Acelrx Pharmaceuticals, INC. | $23.78 | 2020 | |
| Baxter Healthcare | $23.08 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $20.39 | 2020 | |
| Endo Pharmaceuticals INC. | $19.67 | 2020 | |
| Lifenet Health | $18.95 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.26 | 2020 | |
| Bioventus LLC | $14.88 | 2023 | Supartz Fx Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weissberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.